Qiagen NV QGEN shares were spiking higher Monday following the announcement of FDA approval for its molecular diagnostic testing system. Germany-based Qiagen, a provider of sample and assay ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback